Table 1.
Patient Characteristics
| Variable | Value |
|---|---|
| Categorical variable | |
| Sex | |
| Male | 59 (58.4) |
| Female | 42 (41.6) |
| EEG | |
| Normal | 9 (8.9) |
| Abnormal | 92 (91.1) |
| Baclofen | |
| With baclofen | 19 (18.8) |
| Without baclofen | 82 (81.2) |
| Tracheostomy | |
| With tracheostomy | 9 (8.9) |
| Without tracheostomy | 92 (91.1) |
| V-P shunt | |
| With V-P shunt | 5 (5.0) |
| Without V-P shunt | 96 (95.0) |
| Scoliosis | |
| With scoliosis | 36 (35.5) |
| Without scoliosis | 65 (64.4) |
| Feeding route | |
| Oral | 45 (44.6) |
| Nasogastric tube | 48 (47.5) |
| Gastrostomy | 8 (7.9) |
| Main diagnosis | |
| Epilepsy | 67 (66.3) |
| Mitochondrial disease | 19 (18.8) |
| Cerebral palsy | 8 (7.9) |
| Others | 7 (6.9) |
| Brain MRI | |
| Normal | 25 (24.7) |
| Abnormal | 76 (75.2) |
| Total | 101 (100) |
| Continuous variable | |
| Age, mo | 23.4 (10.5–44.1) |
| Disease onset age, mo | 3 (0–6) |
| Duration of disease, mo | 15.4 (7.35–30.75) |
| No. of AED | 3 (2–4) |
Data are presented as number (%) or median (interquartile range).
EEG, electroencephalography; V-P shunt, ventriculoperitoneal shunt; MRI, magnetic resonance imaging; AED, antiepileptic drug.